106: The Elevated PSA Pathway and My Initial Experience with the EpiSwitch PSE Test - Garrett D. Pohlman, MD

Prostate cancer screening is an essential aspect of men's health, and current advancements in testing are making early detection more precise than ever before.

While the PSA (Prostate-Specific Antigen) test has long been the standard, it has limitations and may lead to unnecessary biopsies. The new EpiSwitch PSE test helps differentiate between high and low prostate cancer risks. With an impressive 94% accuracy rate, the EpiSwitch PSE test empowers patients and physicians to make informed decisions.

In this episode, Dr. Garrett Pohlman explores the latest innovations in prostate cancer screening, focusing on the EpiSwitch PSE blood test. 

Stay tuned to discover the benefits of the new EpiSwitch PSE test and learn how precision medicine is reshaping prostate cancer management for men.

Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation.

Show Highlights:

• What are the limitations of the PSA test?